Regeneron Provides Update on Biologics License Application for Linvoseltamab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/10/2026

1. COO
2. CHWY
3. AVAV
4. ASO
5. PLTR
6. NAVN
7. AAPL
8. USAC
9. SAIL
10. M

Go back to Regeneron Provides Update on Biologics License Application for Linvoseltamab
Regeneron (NASDAQ: REGN) Delayed: 803.90 -3.75 (0.46%)
Previous Close $807.65    52 Week High $592.36 
Open $794.36    52 Week Low $325.35 
Day High $804.83    P/E 211.00 
Day Low $794.36    EPS $3.81 
Volume 13,387